Skip to content

Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years.

Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years. Do we Need to Change the Protocol?

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06228261
Acronym
PAT-HMAR
Enrollment
1000
Registered
2024-01-29
Start date
2024-03-15
Completion date
2025-03-15
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Penetrating Abdominal Trauma

Keywords

Penetrating Trauma, Trauma surgery, Explorative laparoscopy, Trauma laparotomy, eFAST

Brief summary

Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Computed Tomography (CT) is widely used in stable patients with PAT and it requires intravenous contrast and patient irradiation, leading to additional costs to healthcare services. This study aims to assess the management of PAT in our institution and with its results review the actual protocol.

Detailed description

Penetrating abdominal trauma (PAT) incidence varies between 3,1-12,8% and it comprises a wide range of injuries with varying patterns on diagnostic imaging. Last guidelines published in 2014 recommend the use of FAST and CXR as the Gold Standard method for evaluating. Computed Tomography (CT) is widely used in stable patients with PAT and it requires intravenous contrast and patient irradiation, leading to additional costs to healthcare services. This study aims to assess the management of PAT in our institution and with its results review the actual protocol. A retrospective unicentric study will be conducted on a prospective database of stab wounds at the Department of General Surgery of Hospital del Mar over a 15-year period. The normality of the distribution of quantitative variables will be assessed using the Kolmogorov-Smirnov test. Comparison between qualitative variable groups will be performed using the Chi-square test or Fisher's exact test when appropriate, and non-parametric tests like the Mann-Whitney U test will be used to evaluate the significance of differences in means of quantitative variables. The odds ratios (OR) of predictor variables with outcome variables will be determined.

Interventions

None listed

Sponsors

Hospital del Mar
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All penetrating trauma patients admitted in the emergency department.

Exclusion criteria

* All patients with any other diagnostic different from penetrating trauma * Blunt trauma patients admitted in the emergency department

Design outcomes

Primary

MeasureTime frameDescription
Complications2008-2023The main outcome measure was the total of complications in patients with a penetrating abdominal trauma assessed by the Clavien-Dindo Classification.
Mortality2008-2023The second main outcome measure was the total of deaths in patients with a penetrating abdominal trauma assessed by preventable or non-preventable deaths.

Secondary

MeasureTime frameDescription
Explorations2008-2023To describe the explorations that has been ordered: eFAST, CT Scan, explorative laparoscopy or laparotomy.
Demographyc description2008-2023Description of the age and gender (Male / Female)
Physiologic description2008-2023Description of the vitals at arrival (bates per minute, blood pressure)
Wound and abdominal exploration2008-2023Description of the wound: bleeding, longitude, number of wounds and the abdominal explorations: peritonism or no peritonism.

Contacts

Primary ContactAna María González Castillo, PhD
amgonzalezcastillo@gmail.com+34665126866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026